Vault-13

Boxer Capital, LLC

San Diego, CA · CIK 1465837 · 13F filing filed 2023-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$2.2bn reported value +5.9% vs Q1 2023
79positions
46.0%in top 10
9 new 5 added 5 reduced 5 sold out vs Q1 2023

Holdings, Q2 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 REATA PHARMACEUTICALS INC CL A RETA RETA 1,430,004 $145.8m6.76% 6.76% AddedShares held: Q3 2022 1.2m, Q4 2022 1.2m, Q1 2023 1.2m, Q2 2023 1.4m +200.0k +200,000 16.3%
2 APELLIS PHARMACEUTICALS INC COM APLS APLS 1,576,000 $143.6m6.66% 6.66% UnchangedShares held: Q3 2022 1.3m, Q4 2022 1.6m, Q1 2023 1.6m, Q2 2023 1.6m
3 REVOLUTION MEDICINES INC COM RVMD RVMD 4,684,264 $125.3m5.81% 5.81% UnchangedShares held: Q3 2022 4.0m, Q4 2022 4.0m, Q1 2023 4.7m, Q2 2023 4.7m
4 TYRA BIOSCIENCES INC COM TYRA TYRA 6,448,359 $109.8m5.09% 5.09% UnchangedShares held: Q3 2022 6.4m, Q4 2022 6.4m, Q1 2023 6.4m, Q2 2023 6.4m
5 SPRINGWORKS THERAPEUTICS INC COM SWTX SWTX 3,421,541 $89.7m4.16% 4.16% UnchangedShares held: Q3 2022 3.4m, Q4 2022 3.4m, Q1 2023 3.4m, Q2 2023 3.4m
6 BEIGENE LTD SPONSORED ADR ONC ONC 500,000 $89.2m4.13% 4.13% UnchangedShares held: Q3 2022 500.0k, Q4 2022 500.0k, Q1 2023 500.0k, Q2 2023 500.0k
7 AKERO THERAPEUTICS INC COM AKRO AKRO 1,676,733 $78.3m3.63% 3.63% AddedShares held: Q3 2022 831.5k, Q4 2022 831.5k, Q1 2023 831.5k, Q2 2023 1.7m +845.2k +845,238 101.7%
8 MIRATI THERAPEUTICS INC COM MRTX MRTX 2,000,000 $72.3m3.35% 3.35% UnchangedShares held: Q3 2022 2.0m, Q4 2022 2.0m, Q1 2023 2.0m, Q2 2023 2.0m
9 SAREPTA THERAPEUTICS INC COM SRPT SRPT 600,000 $68.7m3.19% 3.19% ReducedShares held: Q3 2022 200.0k, Q4 2022 0, Q1 2023 775.0k, Q2 2023 600.0k -175.0k -175,000 -22.6%
10 CYTOKINETICS INC COM NEW CYTK CYTK 2,100,000 $68.5m3.18% 3.18% UnchangedShares held: Q3 2022 2.1m, Q4 2022 2.1m, Q1 2023 2.1m, Q2 2023 2.1m
11 IMMUNOGEN INC COM IMGN IMGN 2,961,000 $55.9m2.59% 2.59% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 3.0m
12 KARUNA THERAPEUTICS INC COM COM 250,000 $54.2m2.51% 2.51% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 250.0k
13 IDEAYA BIOSCIENCES INC COM IDYA IDYA 2,202,812 $51.8m2.40% 2.40% UnchangedShares held: Q3 2022 2.2m, Q4 2022 2.2m, Q1 2023 2.2m, Q2 2023 2.2m
14 SAGE THERAPEUTICS INC COM SAGE SAGE 1,094,000 $51.4m2.39% 2.39% UnchangedShares held: Q3 2022 1.1m, Q4 2022 1.1m, Q1 2023 1.1m, Q2 2023 1.1m
15 NUVALENT INC COM COM 1,210,192 $51.0m2.37% 2.37% UnchangedShares held: Q3 2022 1.2m, Q4 2022 1.2m, Q1 2023 1.2m, Q2 2023 1.2m
16 MERUS N V COM MRUS MRUS 1,900,000 $50.0m2.32% 2.32% UnchangedShares held: Q3 2022 1.9m, Q4 2022 1.9m, Q1 2023 1.9m, Q2 2023 1.9m
17 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 2,084,000 $45.0m2.08% 2.08% UnchangedShares held: Q3 2022 2.1m, Q4 2022 2.1m, Q1 2023 2.1m, Q2 2023 2.1m
18 LEGEND BIOTECH CORP SPONSORED ADS LEGN LEGN 600,000 $41.4m1.92% 1.92% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 600.0k
19 89BIO INC COM ETNB ETNB 2,100,000 $39.8m1.85% 1.85% UnchangedShares held: Q3 2022 1.4m, Q4 2022 1.4m, Q1 2023 2.1m, Q2 2023 2.1m
20 ARCUS BIOSCIENCES INC COM RCUS RCUS 1,602,200 $32.5m1.51% 1.51% AddedShares held: Q3 2022 1.4m, Q4 2022 1.4m, Q1 2023 1.4m, Q2 2023 1.6m +170.0k +170,000 11.9%
21 IVERIC BIO INC COM OPHT OPHT 825,000 $32.5m1.51% 1.51% UnchangedShares held: Q3 2022 0, Q4 2022 825.0k, Q1 2023 825.0k, Q2 2023 825.0k
22 VIKING THERAPEUTICS INC COM VKTX VKTX 2,000,000 $32.4m1.50% 1.50% UnchangedShares held: Q3 2022 0, Q4 2022 1.5m, Q1 2023 2.0m, Q2 2023 2.0m
23 ARGENX SE SPONSORED ADR ARGX ARGX 75,000 $29.2m1.36% 1.36% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 75.0k
24 AMICUS THERAPEUTICS INC COM FOLD FOLD 2,325,000 $29.2m1.35% 1.35% UnchangedShares held: Q3 2022 2.3m, Q4 2022 2.3m, Q1 2023 2.3m, Q2 2023 2.3m
25 ROCKET PHARMACEUTICALS INC COM RCKT RCKT 1,466,051 $29.1m1.35% 1.35% UnchangedShares held: Q3 2022 1.5m, Q4 2022 1.5m, Q1 2023 1.5m, Q2 2023 1.5m
26 AXSOME THERAPEUTICS INC COM AXSM AXSM 400,000 $28.7m1.33% 1.33% UnchangedShares held: Q3 2022 0, Q4 2022 400.0k, Q1 2023 400.0k, Q2 2023 400.0k
27 ITEOS THERAPEUTICS INC COM ITOS ITOS 2,154,058 $28.5m1.32% 1.32% UnchangedShares held: Q3 2022 2.2m, Q4 2022 2.2m, Q1 2023 2.2m, Q2 2023 2.2m
28 VENTYX BIOSCIENCES INC COM VTYX VTYX 850,000 $27.9m1.29% 1.29% UnchangedShares held: Q3 2022 850.0k, Q4 2022 850.0k, Q1 2023 850.0k, Q2 2023 850.0k
29 ANAPTYSBIO INC COM ANAB ANAB 1,300,000 $26.4m1.23% 1.23% UnchangedShares held: Q3 2022 1.3m, Q4 2022 1.3m, Q1 2023 1.3m, Q2 2023 1.3m
30 IOVANCE BIOTHERAPEUTICS INC COM IOVA IOVA 3,705,133 $26.1m1.21% 1.21% UnchangedShares held: Q3 2022 1.9m, Q4 2022 1.5m, Q1 2023 3.7m, Q2 2023 3.7m
31 TANGO THERAPEUTICS INC COM TNGX TNGX 7,123,642 $23.6m1.10% 1.10% UnchangedShares held: Q3 2022 6.9m, Q4 2022 7.1m, Q1 2023 7.1m, Q2 2023 7.1m
32 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 100,000 $23.1m1.07% 1.07% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 100.0k
33 XENON PHARMACEUTICALS INC COM XENE XENE 600,000 $23.1m1.07% 1.07% UnchangedShares held: Q3 2022 600.0k, Q4 2022 600.0k, Q1 2023 600.0k, Q2 2023 600.0k
34 RELAY THERAPEUTICS INC COM RLAY RLAY 1,819,132 $22.8m1.06% 1.06% ReducedShares held: Q3 2022 2.2m, Q4 2022 2.2m, Q1 2023 2.2m, Q2 2023 1.8m -350.0k -350,000 -16.1%
35 POINT BIOPHARMA GLOBAL INC COM COM 2,500,000 $22.6m1.05% 1.05% UnchangedShares held: Q3 2022 2.5m, Q4 2022 2.5m, Q1 2023 2.5m, Q2 2023 2.5m
36 EXELIXIS INC COM EXEL EXEL 1,150,000 $22.0m1.02% 1.02% UnchangedShares held: Q3 2022 1.2m, Q4 2022 1.1m, Q1 2023 1.1m, Q2 2023 1.1m
37 PROTHENA CORP PLC SHS PRTA PRTA 300,000 $20.5m0.95% 0.95% UnchangedShares held: Q3 2022 300.0k, Q4 2022 300.0k, Q1 2023 300.0k, Q2 2023 300.0k
38 PMV PHARMACEUTICALS INC COM PMVP PMVP 3,163,795 $19.8m0.92% 0.92% UnchangedShares held: Q3 2022 3.2m, Q4 2022 3.2m, Q1 2023 3.2m, Q2 2023 3.2m
39 KALVISTA PHARMACEUTICALS INC COM KALV KALV 1,650,000 $14.8m0.69% 0.69% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 1.6m, Q2 2023 1.6m
40 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 710,644 $14.5m0.67% 0.67% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 710.6k, Q2 2023 710.6k
41 DAY ONE BIOPHARMACEUTICALS I COM COM 1,189,943 $14.2m0.66% 0.66% UnchangedShares held: Q3 2022 1.2m, Q4 2022 1.2m, Q1 2023 1.2m, Q2 2023 1.2m
42 ORIC PHARMACEUTICALS INC COM ORIC ORIC 1,732,571 $13.4m0.62% 0.62% AddedShares held: Q3 2022 1.1m, Q4 2022 1.1m, Q1 2023 1.1m, Q2 2023 1.7m +678.6k +678,571 64.4%
43 ZENTALIS PHARMACEUTICALS INC COM ZNTL ZNTL 450,000 $12.7m0.59% 0.59% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 450.0k
44 AVIDITY BIOSCIENCES INC COM RNA RNA 1,121,327 $12.4m0.58% 0.58% UnchangedShares held: Q3 2022 1.1m, Q4 2022 1.1m, Q1 2023 1.1m, Q2 2023 1.1m
45 NURIX THERAPEUTICS INC COM NRIX NRIX 1,224,892 $12.2m0.57% 0.57% UnchangedShares held: Q3 2022 1.2m, Q4 2022 1.2m, Q1 2023 1.2m, Q2 2023 1.2m
46 CULLINAN THERAPEUTICS INC COM CGEM CGEM 1,074,082 $11.6m0.54% 0.54% UnchangedShares held: Q3 2022 1.1m, Q4 2022 1.1m, Q1 2023 1.1m, Q2 2023 1.1m
47 PRELUDE THERAPEUTICS INC COM PRLD PRLD 2,495,018 $11.2m0.52% 0.52% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 699.0k, Q2 2023 2.5m +1.8m +1,795,971 256.9%
48 BLACK DIAMOND THERAPEUTICS I COM BDTX BDTX 2,014,858 $10.2m0.47% 0.47% UnchangedShares held: Q3 2022 2.0m, Q4 2022 2.0m, Q1 2023 2.0m, Q2 2023 2.0m
49 GERON CORP COM GERN GERN 3,000,000 $9.6m0.45% 0.45% NewShares held: Q3 2022 0, Q4 2022 8.1m, Q1 2023 0, Q2 2023 3.0m
50 ASCENDIS PHARMA A/S SPONSORED ADR SPONSORED ADR 95,000 $8.5m0.39% 0.39% UnchangedShares held: Q3 2022 70.0k, Q4 2022 95.0k, Q1 2023 95.0k, Q2 2023 95.0k
51 CENTESSA PHARMACEUTICALS PLC SPONSORED ADS SPONSORED ADS 1,251,137 $7.7m0.36% 0.36% UnchangedShares held: Q3 2022 1.3m, Q4 2022 1.3m, Q1 2023 1.3m, Q2 2023 1.3m
52 CABALETTA BIO INC COM CABA CABA 540,000 $7.0m0.32% 0.32% UnchangedShares held: Q3 2022 540.0k, Q4 2022 540.0k, Q1 2023 540.0k, Q2 2023 540.0k
53 COGENT BIOSCIENCES INC COM COGT COGT 525,000 $6.2m0.29% 0.29% UnchangedShares held: Q3 2022 425.0k, Q4 2022 525.0k, Q1 2023 525.0k, Q2 2023 525.0k
54 DISC MEDICINE INC COM IRON IRON 130,000 $5.8m0.27% 0.27% UnchangedShares held: Q3 2022 0, Q4 2022 130.0k, Q1 2023 130.0k, Q2 2023 130.0k
55 RAPT THERAPEUTICS INC COM COM 300,000 $5.6m0.26% 0.26% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 300.0k, Q2 2023 300.0k
56 2SEVENTY BIO INC COMMON STOCK TSVT TSVT 459,836 $4.7m0.22% 0.22% UnchangedShares held: Q3 2022 459.8k, Q4 2022 459.8k, Q1 2023 459.8k, Q2 2023 459.8k
57 GOSSAMER BIO INC COM GOSS GOSS 3,336,928 $4.0m0.19% 0.19% UnchangedShares held: Q3 2022 3.6m, Q4 2022 3.3m, Q1 2023 3.3m, Q2 2023 3.3m
58 SELECTA BIOSCIENCES INC COM COM 3,284,072 $3.7m0.17% 0.17% UnchangedShares held: Q3 2022 3.3m, Q4 2022 3.3m, Q1 2023 3.3m, Q2 2023 3.3m
59 MERSANA THERAPEUTICS INC COM COM 1,000,000 $3.3m0.15% 0.15% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.0m
60 THESEUS PHARMACEUTICALS INC COM COM 350,000 $3.3m0.15% 0.15% UnchangedShares held: Q3 2022 892.1k, Q4 2022 415.0k, Q1 2023 350.0k, Q2 2023 350.0k
61 MEREO BIOPHARMA GROUP PLC SPON ADS MREO MREO 2,250,000 $3.0m0.14% 0.14% UnchangedShares held: Q3 2022 2.2m, Q4 2022 2.2m, Q1 2023 2.2m, Q2 2023 2.2m
62 DBV TECHNOLOGIES S A SPONSORED ADR SPONSORED ADR 1,450,000 $2.8m0.13% 0.13% UnchangedShares held: Q3 2022 2.1m, Q4 2022 1.4m, Q1 2023 1.4m, Q2 2023 1.4m
63 THIRD HARMONIC BIO INC COM COM 570,417 $2.7m0.13% 0.13% UnchangedShares held: Q3 2022 570.4k, Q4 2022 570.4k, Q1 2023 570.4k, Q2 2023 570.4k
64 FATE THERAPEUTICS INC COM FATE FATE 500,000 $2.4m0.11% 0.11% UnchangedShares held: Q3 2022 350.0k, Q4 2022 1.2m, Q1 2023 500.0k, Q2 2023 500.0k
65 ATRECA INC CL A COM BCEL BCEL 2,202,333 $2.2m0.10% 0.10% UnchangedShares held: Q3 2022 2.2m, Q4 2022 2.2m, Q1 2023 2.2m, Q2 2023 2.2m
66 BIOATLA INC COM BCAB BCAB 686,347 $2.1m0.10% 0.10% UnchangedShares held: Q3 2022 686.3k, Q4 2022 686.3k, Q1 2023 686.3k, Q2 2023 686.3k
67 MILESTONE PHARMACEUTICALS IN COM MIST MIST 698,861 $2.0m0.09% 0.09% UnchangedShares held: Q3 2022 698.9k, Q4 2022 698.9k, Q1 2023 698.9k, Q2 2023 698.9k
68 EQRX INC COM COM 1,000,000 $1.9m0.09% 0.09% UnchangedShares held: Q3 2022 1.0m, Q4 2022 1.0m, Q1 2023 1.0m, Q2 2023 1.0m
69 ORCHESTRA BIOMED HLDGS INC COM OBIO OBIO 250,000 $1.8m0.08% 0.08% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 250.0k, Q2 2023 250.0k
70 KINNATE BIOPHARMA INC COM KNTE KNTE 491,000 $1.5m0.07% 0.07% ReducedShares held: Q3 2022 1.5m, Q4 2022 510.0k, Q1 2023 510.0k, Q2 2023 491.0k -19.0k -19,000 -3.7%
71 RAIN ONCOLOGY INC COM COM 1,152,212 $1.4m0.06% 0.06% ReducedShares held: Q3 2022 1.2m, Q4 2022 2.1m, Q1 2023 2.1m, Q2 2023 1.2m -995.0k -995,000 -46.3%
72 NGM BIOPHARMACEUTICALS INC COM NGM NGM 500,000 $1.3m0.06% 0.06% UnchangedShares held: Q3 2022 500.0k, Q4 2022 500.0k, Q1 2023 500.0k, Q2 2023 500.0k
73 MEI PHARMA INC COM NEW MEIP MEIP 145,654 $958.0k0.04% 0.04% ReducedShares held: Q3 2022 2.9m, Q4 2022 2.9m, Q1 2023 2.9m, Q2 2023 145.7k -2.8m -2,767,437 -95.0%
74 ALAUNOS THERAPEUTICS INC COM COM 1,500,000 $765.0k0.04% 0.04% UnchangedShares held: Q3 2022 1.5m, Q4 2022 1.5m, Q1 2023 1.5m, Q2 2023 1.5m
75 PROTARA THERAPEUTICS INC COM STK TARA TARA 209,227 $500.0k0.02% 0.02% UnchangedShares held: Q3 2022 209.2k, Q4 2022 209.2k, Q1 2023 209.2k, Q2 2023 209.2k
76 VERU INC COM COM 347,300 $413.0k0.02% 0.02% UnchangedShares held: Q3 2022 2.5m, Q4 2022 347.3k, Q1 2023 347.3k, Q2 2023 347.3k
77 BELLICUM PHARMACEUTICALS INC COM NEW BLCM BLCM 450,000 $167.0k0.01% 0.01% NewShares held: Q3 2022 57.0k, Q4 2022 57.0k, Q1 2023 0, Q2 2023 450.0k
78 NUVATION BIO INC *W EXP 07/07/202 NUVB.WS NUVB.WS 266,666 $44.0k0.00% 0.00% UnchangedShares held: Q3 2022 266.7k, Q4 2022 266.7k, Q1 2023 266.7k, Q2 2023 266.7k
79 SURROZEN INC *W EXP 08/01/203 *W EXP 08/01/203 66,666 $4.0k0.00% 0.00% UnchangedShares held: Q3 2022 66.7k, Q4 2022 66.7k, Q1 2023 66.7k, Q2 2023 66.7k

Sold out since Q1 2023

SecurityTickerShares held beforeValue then
PROMETHEUS BIOSCIENCES INC 1,897,500 $203.6m1.9m shares
SEAGEN INC SGEN SGEN 200,000 $40.5m200.0k shares
BELLUS HEALTH INC NEW BLU BLU 3,200,000 $23.0m3.2m shares
MORPHIC HLDG INC MORF MORF 200,000 $7.5m200.0k shares
PANACEA ACQUISITION CORP II 500,000 $5.1m500.0k shares